LeMaitre Vascular, Inc. <LMAT.O>: Barrington Research cuts to market perform from outperform
LMAT•Related News
Easterly Government Properties updates $300 million at-the-market equity program, adds forward sales option
DEA•
Street View: Growth drugs lift Pfizer outlook, but execution remains key
PFE•
SciSparc subsidiary NeuroThera launches Phase IIb Tourette trial site at Yale Child Study Center
SPRC•
Tenda enters Ibovespa first preview for year’s final four-month period
EWZ•
Fed's Kashkari: Communicating Fed's reaction function is helpful
SPY•